HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

What’s On German TV This Month? New Ads From Ursapharm, Protina, Medice And Sanofi

Executive Summary

New German television advertisements for OTC medicines and dietary supplements from Ursapharm for Hylo Care, Protina for Basica Direkt, Medice for Dorithricin and Sanofi for Thomapyrin Tension Duo.

You may also be interested in...



Avoiding ‘Kiss Killers’ – GSK Offers German Consumers New Oral Hygiene Products For The Festival Season

With Carnival season approaching in Germany, GlaxoSmithKline is helping German consumers to take care of their oral hygiene with new toothbrushes and its Zovirax Duo cold sore treatment. 

Health Marketing Round-Up: January 2019

New OTC products and marketing campaigns in Germany, Australia and the UK.

Surviving The Dark German Winter: Four New Dietary Supplements Containing Vitamin D

To help Germans struggling through the dark winter months, Hevert, Cefak, Stada and Doppelherz have all released vitamin D supplements onto the German market.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

RS148489

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel